Ikarian Capital, LLC Cyclerion Therapeutics, Inc. Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.47 - $1.29 $247,907 - $680,425	-527,462 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.96 - $1.78 $23,841 - $44,206	24,835 Added 4.94%	527,462 $585,000
Q3 2021 Nov 15, 2021	SELL	$2.73 - $4.13 $19,920 - $30,136	-7,297 Reduced 1.43%	502,627 $1.54 Million
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.29 $457,634 - $900,573	209,924 Added 69.97%	509,924 $1.99 Million
Q1 2021 May 17, 2021	BUY	$2.69 - $5.12 $807,000 - $1.54 Million	300,000 New	300,000 $836,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $112M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.